• Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., partnered with DPT Laboratories Ltd., of San Antonio, for a supply of Impracor for Phase III trials for musculoskeletal pain. DPT will also carry out work in formulation analysis, validation of quality assurance processes and procedures, and long-term stability testing.